March 9, 2010 – The most recent data from 30 late-breaking clinical trials is being highlighted during the American College of Cardiology (ACC) 2010 scientific sessions, March 14-16 in Atlanta. New this year are the “Trialist Is In” roundtable sessions, held 3:30-4:30 p.m. Sunday and Monday in Hall B2. These are meet-and-greet sessions with...
Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only medication is intended for patients who cannot control their cholesterol levels by diet and exercise alone. It works to reduce your cholesterol in two ways: It reduces the cholesterol...
Headlines
Search the Buyer's Guide
eNewsletters
Industry and technology news, conference updates and quick links to editorial features delivered to your desktop once weekly.
Late-breaking news from key medical conferences with an emphasis on technology introductions and announcements.
Be the first to know... sign up for eNews and receive breaking industry news, FDA announcements and more from our editors and partners.
Featured Video
Multimedia
None available presently.
Do you think transcatheter heart valves will revolutionize how structural heart disease is treated?
Print Edition
The Technology Solutions Resource for Diagnostic and Interventional Cardiology Professionals
Diagnostic & Invasive Cardiology is the widest-reaching provider of new product information, technology trends, application strategies and related connectivity solutions in the diagnostic and interventional cardiology markets.
